Jerusalem Pharmaceutical Co (XPAE:JPH) Cyclically Adjusted Book per Share: $1.95 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAE:JPH Jerusalem Pharmaceutical Co XPAE:JPH
75 GF Score
Price $3.64
GF Value $2.47
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share?

Jerusalem Pharmaceutical Co XPAE:JPH +2.54% 75 Cyclically Adjusted Book per Share is $1.95 as of Jun. 2026. GuruFocus rates XPAE:JPH with a GF Score™ of 75/100 and a GF Value™ of $2.47 (Significantly Overvalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Jerusalem Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was $2.548. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.95 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Jerusalem Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 8.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Jerusalem Pharmaceutical Co was 1.50% per year. The lowest was 1.50% per year. And the median was 1.50% per year.

As of today (2026-09-11), Jerusalem Pharmaceutical Co's current stock price is $3.64. Jerusalem Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was $1.95. Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.87.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Jerusalem Pharmaceutical Co was 2.05. The lowest was 0.90. And the median was 1.14.


Jerusalem Pharmaceutical Co  (XPAE:JPH) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3.64/1.95
=1.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Jerusalem Pharmaceutical Co was 2.05. The lowest was 0.90. And the median was 1.14.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Jerusalem Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Jerusalem Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 1.76 1.63 1.72 1.84

Jerusalem Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.79 1.82 1.84 1.90 1.95

XPAE:JPH vs ZTS, UTHR, VTRS: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jerusalem Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Jerusalem Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


XPAE:JPH
75GF Score
Jerusalem Pharmaceutical Co XPAE:JPH
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jerusalem Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jerusalem Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.548/333.9520*333.9520
=2.548

Current CPI (Jun. 2026) = 333.9520.

Jerusalem Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 1.091 241.428 1.509
201612 1.104 241.432 1.527
201703 1.202 243.801 1.646
201706 1.222 244.955 1.666
201709 1.252 246.819 1.694
201712 1.256 246.524 1.701
201803 1.381 249.554 1.848
201806 1.291 251.989 1.711
201809 1.339 252.439 1.771
201812 1.278 251.233 1.699
201903 1.389 254.202 1.825
201906 1.374 256.143 1.791
201909 1.374 256.759 1.787
201912 1.451 256.974 1.886
202003 1.472 258.115 1.904
202006 1.414 257.797 1.832
202009 1.490 260.280 1.912
202012 1.648 260.474 2.113
202103 1.615 264.877 2.036
202106 1.651 271.696 2.029
202109 1.680 274.310 2.045
202112 1.846 278.802 2.211
202203 1.848 287.504 2.147
202206 1.690 296.311 1.905
202209 1.710 296.808 1.924
202212 1.785 296.797 2.008
202303 1.816 301.836 2.009
202306 1.775 305.109 1.943
202309 1.761 307.789 1.911
202312 1.884 306.746 2.051
202403 1.845 312.332 1.973
202406 1.786 314.175 1.898
202409 1.851 315.301 1.960
202412 1.961 315.605 2.075
202503 2.016 319.799 2.105
202506 2.154 322.561 2.230
202509 2.275 324.800 2.339
202512 2.420 324.054 2.494
202603 2.481 330.213 2.509
202606 2.548 333.952 2.548

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $1.95 mean?
Jerusalem Pharmaceutical Co (XPAE:JPH) has a Cyclically Adjusted Book per Share of $1.95 as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Jerusalem Pharmaceutical Co and its competitors.
Is Jerusalem Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Jerusalem Pharmaceutical Co's current Cyclically Adjusted Book per Share is $1.95. Overall, Jerusalem Pharmaceutical Co has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jerusalem Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Jerusalem Pharmaceutical Co's Cyclically Adjusted Book per Share of $1.95 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Jerusalem Pharmaceutical Co and its competitors. Jerusalem Pharmaceutical Co's current Cyclically Adjusted Book per Share is $1.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jerusalem Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jerusalem Pharmaceutical Co (XPAE:JPH) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.47, compared to a current price of $3.64 — trading 47.4% above its estimated fair value. The current Cyclically Adjusted Book per Share is $1.95. Jerusalem Pharmaceutical Co's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Jerusalem Pharmaceutical Co (XPAE:JPH), the current Cyclically Adjusted Book per Share is $1.95 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jerusalem Pharmaceutical Co (XPAE:JPH) Overvalued in 2026?

Based on GuruFocus' analysis, Jerusalem Pharmaceutical Co stock appears to be overvalued. The current stock price of $3.64 is trading 47.4% above its estimated GF Value™ of $2.47. GuruFocus considers Jerusalem Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for XPAE:JPH:

  • Cyclically Adjusted Book per Share: $1.95
  • GF Value™: $2.47 vs. price of $3.64 (47.4% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the XPAE:JPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jerusalem Pharmaceutical Co Business Description

Address Nablus Street, Jerusalem Pharmaceuticals Company Buliding, Al Bireh Industrial Zone, Al Bireh, PSE, 3570
Jerusalem Pharmaceutical Co is engaged in developing, manufacturing and marketing of human pharmaceuticals products. It also produces detergent, cosmetic, personal and home care products, veterinary and agricultural products. The company operates in Jordan, Algeria, the Middle East, and North Africa Region. Its product portfolio contains more than 300 pharmaceutical products in various dosage forms including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, ointments, as well as ear and nose drops and solutions.
75GF Score

Get the complete analysis for XPAE:JPH

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.64
Price
$2.47
GF Value